Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men between 50 and 80 years of age
- People whose urinary retention (inability to pass urine) has not improved with standard treatments and is caused by a condition called benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland
- People who currently have a urinary catheter (a thin tube inserted to drain the bladder) in place before treatment begins
- People whose prostate size measures between 30 and 80 millilitres on an ultrasound scan
Who may not be able to join:
- People who have previously had surgery on the prostate
- People with a past or current diagnosis of prostate cancer
- People where there is a strong suspicion of prostate cancer — for example, those with a raised PSA level before urinary retention occurred, or an abnormal prostate finding on a physical examination that has not yet been fully investigated
- People known to have a narrowing of the urethra (the tube that carries urine out of the body), bladder stones, or a bladder that does not contract properly
- People with a known neurological condition that may affect how the bladder works, such as Parkinson's disease or a history of stroke
- People for whom the standard surgical procedures used in this trial would not be considered safe — for example, those who are not medically fit for anaesthesia, have an active urinary tract infection, cannot be positioned appropriately for the procedure, have an uncorrectable bleeding disorder, or are taking blood-thinning medications that cannot be safely stopped (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter Ka-Fung CHIU, FRCS, PhD, Chinese University of Hong Kong
Phone: 35051663
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in International Prostate Symptom Score (IPSS) at 12 months after treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.